Hostname: page-component-7c8c6479df-fqc5m Total loading time: 0 Render date: 2024-03-28T04:21:09.670Z Has data issue: false hasContentIssue false

Beneficial effects of probiotic bacteria isolated from breast milk

Published online by Cambridge University Press:  01 October 2007

Federico Lara-Villoslada
Affiliation:
Nutrition and Health Department, Puleva Biotech. Cno, De Purchil no 66, 18004, Granada (Spain)
Mónica Olivares
Affiliation:
Nutrition and Health Department, Puleva Biotech. Cno, De Purchil no 66, 18004, Granada (Spain)
Saleta Sierra
Affiliation:
Nutrition and Health Department, Puleva Biotech. Cno, De Purchil no 66, 18004, Granada (Spain)
Juan Miguel Rodríguez
Affiliation:
Nutrition and Bromatology Department, Universidad Complutense, Ciudad Universitaria, 28040 Madrid (Spain)
Julio Boza
Affiliation:
Nutrition and Health Department, Puleva Biotech. Cno, De Purchil no 66, 18004, Granada (Spain)
Jordi Xaus*
Affiliation:
Nutrition and Health Department, Puleva Biotech. Cno, De Purchil no 66, 18004, Granada (Spain)
*
*Corresponding author: Jordi Xaus Pey, fax+34958240160, email jxaus@pulevabiotech.es
Rights & Permissions [Opens in a new window]

Abstract

Breast milk is the best food for the neonate because it provides a unique combination of proteins, carbohydrates, lipids, minerals and vitamins that ensures the correct growth and development of the infant. In addition, it also contains bioactive compounds responsible for a wide range of beneficial effects such as the promotion of immune system maturation and the protection against infections. Among these bioactive agents, probiotic bacteria have been recently isolated from human milk. The present work reviews the beneficial effects of these bacteria both in animal models and in clinical trials. The promotion of immune system maturation and defence against infections as well as the anti-inflammatory properties are among the main healthy effects of these bacteria. The isolation of probiotic bacteria with beneficial effects for the host provides scientific support for the supplementation of infant formula with these bacteria, in order to advance the pursuit of the main goal of formula: to mimic breast milk and its functional effects as closely as possible.

Type
Full Papers
Copyright
Copyright © The Authors 2007

Human milk is a complex species-specific biological fluid adapted to perfectly satisfy the nutritional and immunological needs of the neonate. It has been demonstrated that breast milk confers protection against different infectious diseases since the incidence of these disorders is lower in breast-fed than in formula-fed infantsReference Lopez-Alarcon, Villalpando and Fajardo1, Reference Wright, Bauer, Naylor, Sutcliffe and Clark2. It has been suggested that this anti-infective effect is due to several bioactive compounds present in colostrum and/or in mature milk. These include immunoglobulins, immune cells, antimicrobial acids, polyamines, oligosaccharides, lysosyme, glycoproteins such as lactoferrin and bioactive peptides, which, acting individually or synergistically, could inhibit pathogenic microorganismsReference Saavedra, Räihä and Rubaltelli3, Reference Isaacs4.

Recent studies have demonstrated that human milk, far from being a sterile fluid, constitutes an excellent and continuous source of commensal bacteria for the infant gutReference Hekkilä and Saris5, Reference Martin, Langa, Reviriego, Jimenez, Marin, Xaus, Fernandez and Rodriguez6. These bacteria could also play an important role in the reduction of incidence and severity of infectious diseases in breastfed children. This hypothesis is supported by relatively old studies reporting the loss of antimicrobial activity in pasteurised human milkReference Ford, Law, Marshall and Reiter7.

Among the bacteria found in human milk, those belonging to the species Staphilococcus, Lactococcus, Enterococcus and Lactobacillus are the most frequentReference Hekkilä and Saris5, Reference Martin, Langa, Reviriego, Jimenez, Marin, Xaus, Fernandez and Rodriguez6 (Table 1). There is increasing interest in some of these breast milk lactobacilli, such as L. gasseri, L. salivarius, L. rhamnosus, L. plantarum and L. fermentum, because they are considered as potentially probiotic species (Table 1).

Table 1 Bacterial species generally isolated from the breast milk of healthy women

Breastfeeding and protection against diseases

In developing countries, one of the main causes of death in the paediatric age group is the infectious disease, specially gastroenterocolitis and respiratory infections. Newborns who have not been breastfed show a 17-fold higher risk of being hospitalised due to pneumonia than those who exclusively received human milkReference Cesar, Victoria and Barros8. Similarly, the risk of death due to diarrhoea increases 14.2-fold in weaned infantsReference Victoria, Smiyh and Vaughan9. Breastfeeding has also been related to a lower incidence of acute otitis mediaReference Duncan, Ey, Holberg, Wright, Martinez and Taussing10, urinary tract infectionReference Pisacane, Graziano, Mazzarella, Scarpellino and Zona11 and meningitis caused by Haemophilus influenzae Reference Silfverdal and Olcen12.

Besides its anti-infective properties, it has been demonstrated that human milk modulates the immune system of the newbornReference Grazioso, Werner and Alling13. Although an anti-inflammatory activity has not yet been demonstrated in vivo, several epidemiologic studies suggest that breast-fed children are protected against infections without the observation of evident lesion of the intestinal or respiratory mucosa due to an inflammatory responseReference Garofalo and Goldman14. This is probably the result of an anti-inflammatory system better regulated by bioactive components of human milk.

The immunomodulatory action of breast milk could also explain the better antibody production response in breast-fed compared to formula-fed infants after vaccination against poliomyelitis, tetanus and diphtheriaReference Hahn-Zoric, Fulconis and Minoli15.

Neonates who received breast milk also have a more favourable intestinal microbiota than those fed infant formulaReference Harmsen, Wildeboer-Veloo and Raangs16, which is probably due to presence of lactic acid bacteria in human milk, besides other bifidogenic compounds such as oligosaccharidesReference Kunz and Rudloff17. It has been suggested that these differences in intestinal microbiota could be responsible for some of the beneficial effects seen in breast-fed infants. It has been known for several decades that lactobacilli and bifidobacteria inhibit the growth of pathogen microorganisms such as Staphylococcus aureus, Salmonella typhimurium, Yersinia enterocolitica and Clostridium perfringens Reference Gilliland and Speck18. These bacteria competitively colonise the intestine of the child, thus preventing the adhesion of pathogens. Moreover, a competition for nutrients is established and this is another mechanism that inhibits the growth of pathogenic microorganismsReference Conway19.

Intestinal colonisation by commensal bacteria also plays a key role in the maintenance of immune system homeostasis. These bacteria stimulate TH1 responses and compensate the trend towards TH2 responses characteristic of the neonatal immune system. It has been reported that the administration of specific probiotics to newborns reduces the incidence of atopic manifestationsReference Kalliomaki, Salminen, Arvilommi, Kero, Koskinen and Isolauri20 and also of inflammatory processes where a TH2 response is involved, such as necrotizing enterocolitisReference Dani, Biandaioli and Firmito21.

Probiotics isolated from breast milk

The description of the presence of bacteria in human milk dates back 30 years, but then it was assumed to be a contamination occurring during sample extractionReference Gavin and Ostovr22. At the beginning of the 21st century, two European groups independently demonstrated the presence of lactic acid bacteria in human milk and their probiotic potentialReference Hekkilä and Saris5, Reference Martin, Langa, Reviriego, Jimenez, Marin, Xaus, Fernandez and Rodriguez6. Thus Heikkilä et al. reported that these human milk bacteria protect both mother and newborn from infections caused by Staphilococcus aureus Reference Hekkilä and Saris5. In a similar way and in a series of reports, Martín et al.Reference Martin, Langa, Reviriego, Jimenez, Marin, Xaus, Fernandez and Rodriguez6 described the isolation of lactic acid bacteria from human milk, namely, L. gasseri CECT5714Reference Martin, Olivares, Marin, Fernandez, Xaus and Rodriguez23, L. salivarius CECT5713Reference Martin, Jimenez, Olivares, Marin, Fernandez, Xaus and Rodriguez24 and L. fermentum CECT5716Reference Martin, Olivares, Marin, Fernandez, Xaus and Rodriguez23. Besides these strains, there are other commercial strains related to human milk. One of them is L. reuteri ATCC55730, which is claimed to be derived from human milk but its origin has not been published yet. L. rhamnosus LGG, although originally isolated from intestinal sourcesReference Conway, Gorbach and Goldin25, has also been found in human milk by the Finnish groupReference Hekkilä and Saris5. Nevertheless, this work focuses on the beneficial effects of L. gasseri CECT5714, L. salivarius CECT5713 and L. fermentum CECT5714, which have been summarised in Table 2.

Table 2 Beneficial effects of some breast milk-isolated probiotic strains

Anti-microbial effects

Protection against viral or bacterial infections is one of the most frequent claims made for probiotic consumption. Different mechanisms have been suggested to explain this anti-microbial activity (Fig. 1). In vitro studies demonstrate that certain probiotic strains produce anti-microbial compounds, such as organic acids, H2O2 and/or bacteriocinsReference Fons, Gomez and Karjalainen26, that have been reported to inhibit the growth of E. coli, Salmonella spp. and Listeria monocytogenes Reference Olivares, Diaz-Ropero, Martin, Rodriguez and Xaus27. No bacteriocin-producing lactobacillus has been found in human milk, although a high production of H2O2 has been reportedReference Martin, Olivares, Marin, Fernandez, Xaus and Rodriguez23. In addition, those strains belonging to the species L. reuteri produce reuterin, another antimicrobial compoundReference Talarico and Dobrogosz28. It has also been shown that some bacteria present in human milk improve the intestinal barrier function by increasing mucine production and reducing intestinal permeabilityReference Olivares, Diaz-Ropero, Martin, Rodriguez and Xaus27. However, competition with entero-toxigenic bacteria for nutrients and for epithelial intestinal cell receptor binding sites is probably the main anti-infective mechanism of probiotic bacteriaReference Fons, Gomez and Karjalainen26, Reference Olivares, Diaz-Ropero, Martin, Rodriguez and Xaus27(Fig. 1).

Fig. 1 Intestinal anti-infective mechanisms of probiotic bacteria.

The human milk-isolated probiotics L. gasseri CECT5714, L. salivarius CECT5713 and L. fermentum CECT5714 have been reported to inhibit the adhesion of Salmonella cholerasuis to mucins and to increase the survival of mice infected with this pathogenReference Olivares, Diaz-Ropero, Martin, Rodriguez and Xaus27. It was demonstrated that the protective effect of L. salivarius CECT5713 is significantly higher than the effect of a reuterin producing strainReference Martin, Olivares, Marin, Xaus, Fernandez and Rodriguez29. This is probably due to the combination of the immunomodulatory role and the competitive activity reported for L. salivarius CECT5713Reference Diaz-Ropero, Martin, Sierra, Lara-Villoslada, Rodriguez, Xaus and Olivares30.

Different clinical trials have demonstrated that, when breastfeeding is not possible, infant formula supplemented with probiotics protect children from infectious diseases. To our knowledge, most of the studies have involved supplementation with L. rhamnosus LGG, which have demonstrated a reduction in the incidence of rotavirus infection and in the duration of diarrhoeaReference Senok, Ismaeel and Botta31. Currently, clinical studies are in progress to evaluate the tolerance and effectiveness of other breast milk strains, such as L. reuteri ATCC55730 and L. salivarius CECT5713.

Immunomodulatory properties

Intestinal colonisation is often the result of the first contact of the newborn with microorganisms, which is crucial for the development of the immune system of the neonate. It has been reported that differences in the composition of intestinal microbiota influence the incidence of certain pathologies with an important immunological component, such as allergic or inflammatory processesReference Björksten, Naaber, Sepp and Mikelsaar32. The anti-allergic effect of probiotics could be explained on the basis of the Hygiene Hypothesis and the TH1/TH2 balance. Probiotics induce a TH1 response, and thus down-regulate the production of TH2 cytokines, responsible for the allergic response.

In contrast, the anti-inflammatory effect of probiotics is more difficult to explain. In vitro studies have demonstrated that the immunomodulatory effects of probiotics depend on the cell environment. Thus, in the absence of additional stimulus, the breast milk probiotics L. salivarius CECT5713 and L. fermentum CECT5716 enhance the production of TH1 cytokines such as IL-2 and IL-12 and the inflammatory mediator TNF-αReference Diaz-Ropero, Martin, Sierra, Lara-Villoslada, Rodriguez, Xaus and Olivares30. However, when cells are incubated in the presence of lipopolysaccharide, together with the probiotics, a reduction of TH1 cytokines is observedReference Diaz-Ropero, Martin, Sierra, Lara-Villoslada, Rodriguez, Xaus and Olivares30. This regulatory mechanism is probably based on the production of IL-10, an immunosuppressive cytokine, which has been reported to be increased by these probiotic strainsReference Diaz-Ropero, Martin, Sierra, Lara-Villoslada, Rodriguez, Xaus and Olivares30.

The immunomodulatory effects of probiotics have also been reported in animal models of pathologies where the immune system is involved. Different probiotic strains isolated from human milk have been reported to enhance the immune defence of mice, increasing both natural and acquired immune responsesReference Diaz-Ropero, Martin, Sierra, Lara-Villoslada, Rodriguez, Xaus and Olivares30. This immune-stimulating activity could be also involved in the anti-infective role previously mentioned for these bacteria in an animal model of Salmonella infectionReference Olivares, Diaz-Ropero, Martin, Rodriguez and Xaus27. In addition, the breast milk probiotic L. gasseri CECT5714 in combination with L. coryniformis CECT5711 reduces the incidence and severity of the allergic response in an animal model of cow's milk protein allergyReference Olivares, Díaz-Ropero, Lara-Villoslada, Rodriguez and Xaus33. In a recent report, L. fermentum CECT5716 showed a beneficial effect in an animal model of intestinal inflammation, reducing the inflammatory response and the intestinal damageReference Peran, Sierra and Comalada34.

Probiotics have also been reported to modulate the immune response of healthy humans, as shown by a recent study which reports an increase in phagocytic activity, in the number of natural killer cells and in the plasma concentration of IgA in healthy humans consuming human milk-isolated probiotics daily for 3 monthsReference Olivares, Diaz-Ropero, Gomez, Lara-Villoslada, Sierra, Maldonado, Martin, Rodriguez and Xaus35. A more recent report demonstrates that the consumption of L. fermentum CECT5716 enhances the response to influenza vaccination in healthy volunteers aged 26-40 and reduces the incidence of influenza-like illnessReference Olivares, Díaz-Ropero, Sierra, Lara-Villoslada, Fonolla, Navas, Rodriguez and Xaus36.

In addition, the beneficial effect of probiotics in allergic processes has been widely reported. In this sense, the consumption of probiotics present in human milk, especially L. rhamnosus LGG, has been shown to reduce the incidence and severity of atopic dermatitis in childrenReference Kalliomaki, Salminen, Arvilommi, Kero, Koskinen and Isolauri20. Although less is known about other allergic disorders, there is data to support a positive effect of L. gasseri CECT5714 in adults with respiratory allergyReference Olivares, Díaz-Ropero, Lara-Villoslada, Rodriguez and Xaus33.

Gastrointestinal benefits

There is increasing interest in the manipulation of intestinal microbiota with the aim of improving gastrointestinal function and nutrient absorption. Different reports demonstrate that human milk probiotics colonise the intestine and increase faecal lactobacilli counts thus modifying intestinal microbiota both in rodentsReference Peran, Camuesco, Comalada, Nieto, Concha, Diaz-Ropero, Olivares, Xaus, Zarzuelo and Galvez37 and humansReference Olivares, Díaz-Ropero, Gomez, Lara-Villoslada, Sierra, Maldonado, Martin, Lopez-Huertas, Rodriguez and Xaus38. In addition, molecular analysis show that these bacteria are metabolically active in the human gut, increasing the production of functional metabolites such as butyrateReference Olivares, Díaz-Ropero, Gomez, Lara-Villoslada, Sierra, Maldonado, Martin, Lopez-Huertas, Rodriguez and Xaus38, which is the main energy source for colonocytes and plays a key role in the modulation of intestinal function. In the previously mentioned clinical trialReference Olivares, Díaz-Ropero, Gomez, Lara-Villoslada, Sierra, Maldonado, Martin, Lopez-Huertas, Rodriguez and Xaus38, an increase in faecal moisture, and in stool frequency and volume was observed which could be related to the increase in the faecal concentration of butyric acid.

Similarly, the administration of L. gasseri CECT5714 also caused an increase in faecal lactobacilli counts in a clinical trial in children aged 3-12Reference Lara-Villoslada, Sierra, Boza, Xaus and Olivares39. In the same study the cytotoxicity of the faecal water of children who received the probiotic has been shown to be lower than that of the control childrenReference Lara-Villoslada, Sierra, Boza, Xaus and Olivares39. Finally, in another clinical trial the supplementation of infant formulas with L. rhamnosus LGG has been demonstrated to improve neonate growth pattern, which could suggest an increased bioavailability of nutrients in these infantsReference Vendt, Grünberg, Tuure, Malminiemi, Wuolijoki, Tillmann, Sepp and Korpela40.

Conclusions

Breastfeeding is the main determinant of the intestinal colonisation of the neonate, which, apart from other components, is due to the recently discovered presence of probiotic bacteria in human milk. In addition to gastrointestinal benefits, modulation of microbiota by probiotic bacteria has been shown to regulate the immune function and to enhance defence against intestinal pathogens. Thus, the addition of breast milk probiotics to infant formulas could be a new alternative to mimic some of the functional effects of human milk in children who are not breastfed.

Conflict of interest statement

All the authors except JMR are employees at Puleva Biotech SA. All the studies presented have been funded by Puleva Biotech's own founds. This review has mainly been written by JX with collaboration of all the other authors.

References

1Lopez-Alarcon, M, Villalpando, S & Fajardo, A (1997) Breastfeeding lowers the frequency and duration of acute respiratory infection and diarrhea in infants under six months of age. J Nutr 127, 436443.Google Scholar
2Wright, AL, Bauer, M, Naylor, A, Sutcliffe, E & Clark, L (1998) Increasing breastfeeding rates to reduce infant illness at the community level. Pediatrics 101, 837844.Google Scholar
3Saavedra, JM (2002) Probiotic agents: clinical applications in infants and children. In Infant formula: closer to reference, pp. 1527 [Räihä, NCR and Rubaltelli, FF, editors]. Philadelphia: Lippincott Williams & Wilkins.Google Scholar
4Isaacs, CE (2005) Human milk inactivates pathogen individually, additively and sinergistically. J Nutr 51, 12861288.Google Scholar
5Hekkilä, MP & Saris, PEJ (2003) Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. J Appl Microbiol 95, 471478.Google Scholar
6Martin, R, Langa, S, Reviriego, C, Jimenez, E, Marin, ML, Xaus, J, Fernandez, L & Rodriguez, JM (2003) Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr143, 754758.Google Scholar
7Ford, JE, Law, BA, Marshall, VME & Reiter, B (1977) Influence of the heat treatment of human milk on some of its protective constituents. J Pediatr 91, 2935.Google Scholar
8Cesar, JA, Victoria, CG, Barros, FC, et al. (1999) Impact of breast feeding on admission for pneumonia in postneonatal period in Brazil: nested case-control study. BMJ 318, 13161320.Google Scholar
9Victoria, CG, Smiyh, PG, Vaughan, JP, et al. (1987) Evidence for protection by breast-feeding against infant deaths from infectious diseases in Brazil. Lancet II 319322.Google Scholar
10Duncan, B, Ey, J, Holberg, CJ, Wright, AL, Martinez, FD & Taussing, LM (1994) Exclusive breast-feeding for at least 4 months protects against otitis media. Pediatrics 91, 867871.Google Scholar
11Pisacane, A, Graziano, L, Mazzarella, G, Scarpellino, B & Zona, G (1992) Breast-feeding and urinary tract infections. J Pediatr 121, 331332.Google Scholar
12Silfverdal, AS & Olcen, P (1999) Protective effect of breastfeeding: an ecologic study of Haemophilus influenzae meningitis and breastfeeding in a Swedish population. Int J Epidemiol 28, 152156.Google Scholar
13Grazioso, CF, Werner, AL, Alling, DW, et al. (1997) Antiinflammatory effects of human milk on chemically induced colitis in rats. Pediatr Res 42, 639643.Google Scholar
14Garofalo, RP & Goldman, AP (1999) Expression of functional immunomodulatory and antiinflammatory factors in human milk. Clin Perinatol 26, 361367.Google Scholar
15Hahn-Zoric, M, Fulconis, F, Minoli, L, et al. (1990) Antibody response to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatr Scand 79, 11371142.Google Scholar
16Harmsen, HJM, Wildeboer-Veloo, ACM, Raangs, GC, et al. (2000) Analysis of intestinal flora development in breast-fed infants by using molecular identification and detection methods. J Pediatr Gstroenterol Nutr 30, 6167.Google Scholar
17Kunz, C & Rudloff, S (1993) Biological functions of oligosaccharides in human milk. Acta Paediatr 82, 903912.Google Scholar
18Gilliland, SE & Speck, ML (1977) Antagonistic action of lactobacillus acidophilus toward intestinal and food borne pathogens in associative cultures. J food Prot 40, 820823.Google Scholar
19Conway, PL (1996) Selection criteria for probiotic microorganisms. Asia pacific J Clin Nutr 5, 1014.Google Scholar
20Kalliomaki, M, Salminen, S, Arvilommi, H, Kero, P, Koskinen, P & Isolauri, E (2001) Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 357, 10761079.Google Scholar
21Dani, C, Biandaioli, R & Firmito, FR (2002) Potential role of probiotics in the prevention of necrotizing enterocolitis. In Infant formula: Closer to the reference. Philadelphia: Lippincott Williams & Wilkins.Google Scholar
22Gavin, A & Ostovr, KMicrobiological characterization of human milk (1977) J Food Prot 40, 614616.Google Scholar
23Martin, R, Olivares, M, Marin, ML, Fernandez, L, Xaus, J & Rodriguez, JM (2005) Probiotic potential of 3 lactobacilli strains isolated from breast milk. Hum Lact 21, 817.Google Scholar
24Martin, R, Jimenez, E, Olivares, M, Marin, ML, Fernandez, L, Xaus, J & Rodriguez, JM (2006) Lactobacillus salivarius CECT5713, a potential probiotic strain isolated from infant feces and breast milk of a mother-child pair. Int J Microbiol 112, 3543.Google Scholar
25Conway, PL, Gorbach, SL & Goldin, BR (1987) Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 70, 112.Google Scholar
26Fons, M, Gomez, A & Karjalainen, T (2000) Mechanisms of colonization and colonization resistance of the digestive tract. Microb Ecol Health Dis 2, 240246.Google Scholar
27Olivares, M, Diaz-Ropero, MP, Martin, R, Rodriguez, JM & Xaus, J (2006) Antimicrobial potential of four lactobacillus strains isolated from breast milk. J Appl Microbiol 101, 7279.Google Scholar
28Talarico, TL & Dobrogosz, WJ (1989) Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri. Antimicrob Agents Chemother 33, 674679.Google Scholar
29Martin, R, Olivares, m, Marin, ML, Xaus, J, Fernandez, L & Rodriguez, JM (2005) Characterization of a reuterin-producing Lactobcillus coryniformis strain isolated from a goat's milk cheese. Int J Food Microbiol 104, 267277.Google Scholar
30Diaz-Ropero, MP, Martin, R, Sierra, S, Lara-Villoslada, F, Rodriguez, JM, Xaus, J & Olivares, M (2006) Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response. J Appl Microbiol 102, 337343.Google Scholar
31Senok, AC, Ismaeel, AY & Botta, GA (2005) Probiotics: facts and myths. Clin Microb Infect 11, 958966.Google Scholar
32Björksten, B, Naaber, P, Sepp, E & Mikelsaar, M (1999) The gut microflora in allergic Estonian and sweedish 2-year-old children. Clin Exp Allergy 29, 342346.Google Scholar
33Olivares, M, Díaz-Ropero, MP, Lara-Villoslada, F, Rodriguez, JM & Xaus, J (2005) Efectiveness of probiotics in allergy: child's game or adult affair? Nutrafoods 4, 5964.Google Scholar
34Peran, L, Sierra, S, Comalada, M, et al. (2007) A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br J Nutr 97, 96103.Google Scholar
35Olivares, M, Diaz-Ropero, MP, Gomez, N, Lara-Villoslada, F, Sierra, S, Maldonado, JM, Martin, R, Rodriguez, JM & Xaus, J (2006) The consumption of two new probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, boost the immune system of healthy adults. Int Microbiol 9, 4752.Google Scholar
36Olivares, M, Díaz-Ropero, MP, Sierra, S, Lara-Villoslada, F, Fonolla, J, Navas, M, Rodriguez, JM & Xaus, J (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effect of influenza vaccination. Nutrition 23, 254260.Google Scholar
37Peran, L, Camuesco, D, Comalada, M, Nieto, A, Concha, A, Diaz-Ropero, MP, Olivares, M, Xaus, J, Zarzuelo, A & Galvez, J (2005) Preventative effects of a probiotic, Lactobacillus salivarius ssp salivarius, in the TNBS model of rat colitis. World J Gastroenterol 11, 51855192.Google Scholar
38Olivares, M, Díaz-Ropero, MP, Gomez, N, Lara-Villoslada, F, Sierra, S, Maldonado, JA, Martin, R, Lopez-Huertas, E, Rodriguez, JM & Xaus, J (2006) Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults. Int J Microbiol 107, 104111.Google Scholar
39Lara-Villoslada, F, Sierra, S, Boza, J, Xaus, J & Olivares, M (2007) Beneficial effects of consumption of a dairy product containing two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714n in healthy children. Nutr Hosp. 4, 22, 496502.Google Scholar
40Vendt, N, Grünberg, H, Tuure, T, Malminiemi, O, Wuolijoki, E, Tillmann, V, Sepp, E & Korpela, R (2006) Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: doble-blind, randomized trial. J Hum Nutr Dietet 19, 5158.Google Scholar
Figure 0

Table 1 Bacterial species generally isolated from the breast milk of healthy women

Figure 1

Table 2 Beneficial effects of some breast milk-isolated probiotic strains

Figure 2

Fig. 1 Intestinal anti-infective mechanisms of probiotic bacteria.